Cansu Demirbatir

Dr. Cansu Demirbatir

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
YHYeşim HAMURTEKİN
Yeşim HAMURTEKİN
ANAmmar Nouilati
Ammar Nouilati
CDCansu Demirbatir
Cansu Demirbatir
EHEmre Hamurtekin
Emre Hamurtekin
Acetaminophen is a widely used analgesic and antipyretic agent. It is also available in over the counter formulations, which has increased its wide use. There have been many studies to date that have aimed to evaluate the mechanism of the analgesic action of acetaminophen. Additional to the inhibition of the cyclooxygenase pathway in the central nervous system, the involvement of opioidergic, cannabinoidergic, dopaminergic, cholinergic, and nitrergic systems as well as the contribution of descending pain inhibitory systems like the bulbospinal serotonergic pathway has been proposed as possible mechanisms of the analgesic action of acetaminophen. In this review, we aimed to collect the data from studies revealing the contribution of the central serotonergic system and the role of central nervous system-located serotonergic receptor subtypes in the analgesic effect of acetaminophen. While doing this, we mainly focused on the research that has been performed in the last ten years and tried to link the previous data with the lately added results. In addition to serotonergic system involvement, we also reviewed the role of nitric oxide in the analgesic action of acetaminophen, especially with the new findings reported over the last decade.

25 September 2026 in Acta Microbiologica Hellenica
Verified
Journal Article
Open access
PDF file
HHHaskologlu, Ismail Celil Haskologlu
Haskologlu, Ismail Celil Haskologlu
AAAbdullah Jaafar Abdulkareem
Abdullah Jaafar Abdulkareem
CDCansu Demirbatir
Cansu Demirbatir
Viral encephalitis is a severe neurological condition in which direct viral injury and dysregulated neuroimmune responses jointly determine disease progression and long-term outcomes. Microglia are central to this process, supporting antiviral defense and tissue repair while also contributing to excessive inflammation and neuronal damage. Growing evidence indicates that microglial functions and antiviral immunity are temporally regulated by molecular circadian clocks. Melatonin may connect these systems through its chronobiotic, immunomodulatory, antioxidant, and mitochondrial effects. This comprehensive review examines whether melatonin and circadian clock pathways modulate microglial states and functions during viral encephalitis. We integrate evidence from neurotropic viral infections, experimental encephalitis models, and mechanistic studies of clock–immune interactions, with emphasis on CLOCK–BMAL1, PER–CRY, REV-ERB–ROR, NF-κB, type I interferon, and NLRP3 signaling. Current findings suggest that the effects of melatonin are context-dependent and may vary according to viral species, dose, circadian phase, cellular target, and disease stage. Although preclinical observations support the individual components of a potential chrono-immunological framework, evidence directly integrating these components remains limited. Future studies should incorporate time-of-day-controlled designs, dynamic microglial phenotyping, and stage-specific melatonin administration. Understanding this axis may enable more precise chronotherapeutic strategies that preserve antiviral immunity while limiting neuroinflammatory injury.